$6,999.00
In Stock
Vitrakvi is a drug from the group of antitumor drugs.
It represents a pharmacotherapeutic group of protein kinase inhibitors. It is available in the form of capsules in – 100 mg. The drug is also available in the form of a solution for oral administration (20 mg / ml).
Larotrectinib demonstrates its effectiveness against malignant neoplasms regardless of their localization in the body. This drug is designed to treat cancer with certain genetic features. The active component of the drug is able to recognize certain types of cancer cells and block them, which allows slowing down or stopping tumor growth.
It is used as monotherapy for the treatment of adults and children with locally advanced and metastatic solid tumors with neurotrophic tyrosine kinase receptor (NTRK) gene fusion, where surgical resection can lead to severe complications, and for which there are no adequate treatment options.
Active ingredient: larotrectinib
Prescription drug
The drug is delivered from Germany
